These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10529775)

  • 1. What is the real role of CD40 in cancer immunotherapy?
    Costello RT; Gastaut JA; Olive D
    Immunol Today; 1999 Nov; 20(11):488-93. PubMed ID: 10529775
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system.
    Phipps RP
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):6930-2. PubMed ID: 10860949
    [No Abstract]   [Full Text] [Related]  

  • 3. CD40 and its ligand in host defense.
    Noelle RJ
    Immunity; 1996 May; 4(5):415-9. PubMed ID: 8630727
    [No Abstract]   [Full Text] [Related]  

  • 4. CD40-CD40 ligand interaction in autoimmune disease.
    Datta SK; Kalled SL
    Arthritis Rheum; 1997 Oct; 40(10):1735-45. PubMed ID: 9336404
    [No Abstract]   [Full Text] [Related]  

  • 5. Functional role of CD40 and its ligand.
    van Kooten C; Banchereau J
    Int Arch Allergy Immunol; 1997 Aug; 113(4):393-9. PubMed ID: 9250584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A central role of CD40 ligand in the regulation of CD4+ T-cell responses.
    Grewal IS; Flavell RA
    Immunol Today; 1996 Sep; 17(9):410-4. PubMed ID: 8854557
    [No Abstract]   [Full Text] [Related]  

  • 7. CD40L gene transfer in immunotherapy of cancer: more than co-stimulation?
    Bergmann C; Brandau S
    Cancer Biol Ther; 2009 Jan; 8(2):143-5. PubMed ID: 19106641
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of CD40-CD40-ligand interaction in Ig-isotype switching.
    Fuleihan R; Ramesh N; Geha RS
    Curr Opin Immunol; 1993 Dec; 5(6):963-7. PubMed ID: 7507684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD40 and its ligand in autoimmunity.
    Noelle RJ; Mackey M; Foy T; Buhlmann J; Burns C
    Ann N Y Acad Sci; 1997 Apr; 815():384-91. PubMed ID: 9186684
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential for blockade of the CD40 ligand, gp39.
    Buhlmann JE; Noelle RJ
    J Clin Immunol; 1996 Mar; 16(2):83-9. PubMed ID: 8690776
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-CD 40 monoclonal antibody.
    Geldart T; Illidge T
    Leuk Lymphoma; 2005 Aug; 46(8):1105-13. PubMed ID: 16085550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of CDX-1140, an agonist CD40 antibody for cancer immunotherapy.
    Vitale LA; Thomas LJ; He LZ; O'Neill T; Widger J; Crocker A; Sundarapandiyan K; Storey JR; Forsberg EM; Weidlick J; Baronas AR; Gergel LE; Boyer JM; Sisson C; Goldstein J; Marsh HC; Keler T
    Cancer Immunol Immunother; 2019 Feb; 68(2):233-245. PubMed ID: 30382327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged anti-CD40 ligand therapy improves primate cardiac allograft survival.
    Chang AC; Blum MG; Blair KS; Scott MA; Brock JE; Thomas DW; Burkly LC; Miller GG; Pierson RN
    Transplant Proc; 1999; 31(1-2):95. PubMed ID: 10083025
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of CD40 and its ligand in the regulation of the immune response.
    Hollenbaugh D; Ochs HD; Noelle RJ; Ledbetter JA; Aruffo A
    Immunol Rev; 1994 Apr; 138():23-37. PubMed ID: 7520883
    [No Abstract]   [Full Text] [Related]  

  • 15. CD40 and its ligand.
    Clark LB; Foy TM; Noelle RJ
    Adv Immunol; 1996; 63():43-78. PubMed ID: 8787629
    [No Abstract]   [Full Text] [Related]  

  • 16. CD40-CD40 ligand.
    van Kooten C; Banchereau J
    J Leukoc Biol; 2000 Jan; 67(1):2-17. PubMed ID: 10647992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functions of CD40 on B cells, dendritic cells and other cells.
    van Kooten C; Banchereau J
    Curr Opin Immunol; 1997 Jun; 9(3):330-7. PubMed ID: 9203418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies.
    Fiumara P; Younes A
    Br J Haematol; 2001 May; 113(2):265-74. PubMed ID: 11380390
    [No Abstract]   [Full Text] [Related]  

  • 19. CD40-CD154 interactions in B-cell signaling.
    Calderhead DM; Kosaka Y; Manning EM; Noelle RJ
    Curr Top Microbiol Immunol; 2000; 245(2):73-99. PubMed ID: 10533319
    [No Abstract]   [Full Text] [Related]  

  • 20. CD40-CD40 ligand (CD154) engagement is required but may not be sufficient for human T helper 1 cell induction of interleukin-2- or interleukin-15-driven, contact-dependent, interleukin-1beta production by monocytes.
    Ribbens C; Dayer JM; Chizzolini C
    Immunology; 2000 Feb; 99(2):279-86. PubMed ID: 10692048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.